central non-small cell lung cancer
Conditions
Interventions
Group 1:intensity modulated radiation therapy
Group 2:stereotactic body radiation therapy
Sponsors
Department of Radiation Oncology, PLA 307 Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: The central NSCLC patients with stage III or stage IV which is systemic disease control, residual lung disease, lung lesions in the central area, away from the trachea or main bronchus 6 months.
Exclusion criteria
Exclusion criteria: The patients have serious medical disorders and uncontrolled infection; the patients have serious organic disease, or vital organ failure, such as decompensated heart, lung, kidney failure as a result of patients can not tolerate treatment; while using other experimental drugs or other clinical trials; neuropsychiatric disorders; the patients can not understand, with assessment before and after treatment; previously had chest radiotherapy; effective medical treatment without radiotherapy; KPS score <70; =2 an organ metastasis; expected survival of <6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| short term effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.5-year PFS;toxicity;oregional recurrent-free survival rate (LRRFS);OS; | — |
Countries
China
Contacts
Public ContactShen Ge
Outcome results
None listed